Davidson B - Search Results

1

Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohort.

Azad N, Yu M, Davidson B, Choyke P, Chen CC, Wood BJ, Venkatesan A, Henning R, Calvo K, Minasian L, Edelman DC, Meltzer P, Steinberg SM, Annunziata CM, Kohn EC. Azad N, et al. Among authors: davidson b. Mol Cell Proteomics. 2013 Jun;12(6):1621-31. doi: 10.1074/mcp.M112.026427. Epub 2013 Feb 28. Mol Cell Proteomics. 2013. PMID: 23449826 Free PMC article. Clinical Trial.

2

Adhesion molecule protein signature in ovarian cancer effusions is prognostic of patient outcome.

Kim G, Davidson B, Henning R, Wang J, Yu M, Annunziata C, Hetland T, Kohn EC. Kim G, et al. Among authors: davidson b. Cancer. 2012 Mar 15;118(6):1543-53. doi: 10.1002/cncr.26449. Epub 2011 Aug 25. Cancer. 2012. PMID: 22009736 Free PMC article.

3

Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer.

Hernandez L, Hsu SC, Davidson B, Birrer MJ, Kohn EC, Annunziata CM. Hernandez L, et al. Among authors: davidson b. Cancer Res. 2010 May 15;70(10):4005-14. doi: 10.1158/0008-5472.CAN-09-3912. Epub 2010 Apr 27. Cancer Res. 2010. PMID: 20424119 Free PMC article.

4

Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer.

Annunziata CM, Stavnes HT, Kleinberg L, Berner A, Hernandez LF, Birrer MJ, Steinberg SM, Davidson B, Kohn EC. Annunziata CM, et al. Among authors: davidson b. Cancer. 2010 Jul 1;116(13):3276-84. doi: 10.1002/cncr.25190. Cancer. 2010. PMID: 20564628 Free PMC article.

5

Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling.

Davidson B, Espina V, Steinberg SM, Flørenes VA, Liotta LA, Kristensen GB, Tropé CG, Berner A, Kohn EC. Davidson B, et al. Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):791-9. doi: 10.1158/1078-0432.CCR-05-2516. Clin Cancer Res. 2006. PMID: 16467090

6

Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review of the recent literature.

Posadas EM, Davidson B, Kohn EC. Posadas EM, et al. Among authors: davidson b. Curr Opin Oncol. 2004 Sep;16(5):478-84. doi: 10.1097/00001622-200409000-00012. Curr Opin Oncol. 2004. PMID: 15314519 Review.

7

BAG-4/SODD and associated antiapoptotic proteins are linked to aggressiveness of epithelial ovarian cancer.

Annunziata CM, Kleinberg L, Davidson B, Berner A, Gius D, Tchabo N, Steinberg SM, Kohn EC. Annunziata CM, et al. Among authors: davidson b. Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6585-92. doi: 10.1158/1078-0432.CCR-07-0327. Clin Cancer Res. 2007. PMID: 18006758

8

IKK-ε coordinates invasion and metastasis of ovarian cancer.

Hsu S, Kim M, Hernandez L, Grajales V, Noonan A, Anver M, Davidson B, Annunziata CM. Hsu S, et al. Among authors: davidson b. Cancer Res. 2012 Nov 1;72(21):5494-504. doi: 10.1158/0008-5472.CAN-11-3993. Epub 2012 Aug 31. Cancer Res. 2012. PMID: 22942254 Free PMC article.

9

The anti-apoptotic activity of BAG3 is restricted by caspases and the proteasome.

Virador VM, Davidson B, Czechowicz J, Mai A, Kassis J, Kohn EC. Virador VM, et al. Among authors: davidson b. PLoS One. 2009;4(4):e5136. doi: 10.1371/journal.pone.0005136. Epub 2009 Apr 8. PLoS One. 2009. PMID: 19352495 Free PMC article.

10

Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma.

Elstrand MB, Kleinberg L, Kohn EC, Tropé CG, Davidson B. Elstrand MB, et al. Among authors: davidson b. Int J Gynecol Pathol. 2009 May;28(3):211-21. doi: 10.1097/PGP.0b013e31818b0f5e. Int J Gynecol Pathol. 2009. PMID: 19620938

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,496 results

Search Page